Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China flag China · Delayed Price · Currency is CNY
8.55
-0.18 (-2.06%)
Nov 13, 2026, 3:04 PM CST

SHE:002693 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
44.0119.04-78.3-50.749.01-20.33
Depreciation & Amortization
52.7352.6253.4852.6757.5454.33
Other Amortization
2.492.481.981.370.981.16
Loss (Gain) From Sale of Assets
-0.01-0.010.02-0.47-29.91-13.79
Asset Writedown & Restructuring Costs
2.882.8819.010.122.120.05
Loss (Gain) From Sale of Investments
-0.57-0.579.437.1-4.63-4.12
Provision & Write-off of Bad Debts
0.090.090.181.15-0.09-0.05
Other Operating Activities
-8.912.26-18.42-8.29-5.27-8.61
Change in Accounts Receivable
-51.02-51.02-3.484.99-13.835.39
Change in Inventory
11.9411.94-19.76-12.45-9.89-4.77
Change in Accounts Payable
22.0122.01-5.02-9.6619.5713.83
Change in Other Net Operating Assets
----3.17--
Operating Cash Flow
74.8760.95-40.8311.6425.2223.55
Operating Cash Flow Growth
582.96%---53.84%7.07%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-47.61-43.27-24.91-49.2-32.98-31.64
Sale of Property, Plant & Equipment
0.881.060.789.8326.9821.67
Investment in Securities
20.66-0.2828.4861.03-83.7638.85
Other Investing Activities
0.490.560.692.754.694.12
Investing Cash Flow
-25.58-41.935.0424.42-85.0732.99

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-8.4922.4522.947.61-
Long-Term Debt Issued
-2980-50-
Total Debt Issued
28.4937.49102.4522.9457.61-
Short-Term Debt Repaid
--7.35-1.83-1.15--
Long-Term Debt Repaid
--28-12.5-60-12-55.34
Total Debt Repaid
-46.35-35.35-14.33-61.15-12-55.34
Net Debt Issued (Repaid)
-17.852.1588.12-38.245.61-55.34
Issuance of Common Stock
--0.427.4210.4513.37
Common Dividends Paid
-7.09-7.27-7.19-8.69-11.13-9.1
Other Financing Activities
-1.61--4.01--10.45
Financing Cash Flow
-28.05-5.1277.34-39.4744.93-40.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-1.190.040.17-00.1-0.11
Net Cash Flow
20.0513.9441.72-3.41-14.8215.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
27.2617.68-65.73-37.56-7.77-8.09
Free Cash Flow Growth
------
Free Cash Flow Margin
9.10%6.39%-37.73%-15.92%-2.83%-2.52%
Free Cash Flow Per Share
0.070.05-0.16-0.09-0.02-0.02
Levered Free Cash Flow
86.9911.71-31.22-31.8-23.4827.13
Unlevered Free Cash Flow
88.5117.74-25.45-25.81-16.4932.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
25.2214.1514.8431.9218.0431.61
Change in Working Capital
-17.84-17.84-28.16-21.27-4.5314.9